Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge
1 other identifier
interventional
70
1 country
1
Brief Summary
This study aims to evaluate the feasibility, usability, and clinical effectiveness of a digital rehabilitation platform in adult patients discharged from the intensive care unit (ICU). Adult patients aged 19 years or older who stayed in the ICU for more than 48 hours and are capable of using a smartphone will be enrolled from two tertiary hospitals in South Korea. Participants will receive individualized rehabilitation programs using a digital rehabilitation platform ("Tuntun Rehabilitation Assistant") based on their functional status. Rehabilitation will be conducted once daily for up to 30 minutes per session. Physical and cognitive function outcomes will be assessed at baseline, two weeks after intervention initiation, at hospital discharge, and during follow-up when applicable. This prospective cohort study will investigate changes in physical function, mobility, cognitive status, and quality of life, as well as platform usage and safety-related events, to determine the clinical usefulness of digital rehabilitation for ICU survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2026
CompletedStudy Start
First participant enrolled
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 23, 2026
March 1, 2026
11 months
January 13, 2026
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Medical Research Council Sum Score (MRC-SS)
Summation score of muscle strength based on MRC scale. Unit of Measure: Sum score (0 to 60, where a higher score indicates better overall muscle strength.)
From enrollment to the end of treatment at 2 weeks
Functional Ambulatory Category (FAC)
Measurement of the level of ambulation and assistance required. Unit of Measure: FAC score (0 to 5, where a higher score indicates greater walking independence.)
From enrollment to the end of treatment at 2 weeks
Mini-Mental State Examination (MMSE)
Cognitive function assessment using the MMSE tool. Unit of Measure: MMSE score (0 to 30, where a higher score indicates better cognitive function.)
From enrollment to the end of treatment at 2 weeks
EQ-5D-5L
Assessment of patient-reported quality of life using the EQ-5D-5L questionnaire, which includes five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on a 5-level scale. Responses were converted to a utility index score. Unit of Measure: Utility score (0 to 1).
From enrollment to the end of treatment at 2 weeks
EQ-5D VAS
Assessment of patient-reported quality of life using the EQ-5D visual analog scale (VAS), where participants rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health). Unit of Measure: VAS score (0 to 100).
From enrollment to the end of treatment at 2 weeks
SLR time
Assessment of straight leg raise (SLR) repetitions over 60 seconds and static holding ability. Unit of Measure: time (seconds) (For time: A higher value indicates better static endurance.)
From enrollment to the end of treatment at 2 weeks
SLR count
Assessment of straight leg raise (SLR) repetitions performed within 60 seconds. Unit of Measure: Count (repetitions) (For count: A higher value indicates better performance.)
From enrollment to the end of treatment at 2 weeks
Short Physical Performance Battery (SPPB) Total Score
Assessment of lower extremity physical performance using the Short Physical Performance Battery (SPPB), which includes balance tests, gait speed, and repeated chair stand tests. Scores range from 0 to 12, with higher scores indicating better physical performance. Unit of Measure: Total score (0 to 12).
From enrollment to the end of treatment at 2 weeks
Study Arms (1)
Digital Rehabilitation Group
EXPERIMENTALInterventions
The Tuntun Rehabilitation Assistant is a smartphone-based digital rehabilitation platform designed for patients discharged from the intensive care unit. Rehabilitation sessions are conducted once daily, with each session lasting up to 30 minutes. During the initial five sessions, a researcher assists participants in performing the intervention in the hospital room. Thereafter, participants independently perform the prescribed exercises using the digital platform. The intervention is continued during hospitalization and, when applicable, after discharge until outpatient follow-up.
Eligibility Criteria
You may qualify if:
- Age 19 years or older.
- Admission to the intensive care unit (ICU) for more than 48 hours.
- Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
- Discharge from the ICU at the time of enrollment.
- Ownership of a smartphone and ability to operate a digital rehabilitation platform.
- Ability to understand the study procedures and provide voluntary written informed consent.
You may not qualify if:
- Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
- Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
- Unstable medical conditions requiring ongoing intensive medical treatment.
- Inability to use a smartphone or digital platform independently.
- Refusal to participate or withdrawal of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asan Medical Centerlead
- Seoul National University Bundang Hospitalcollaborator
- EverEx Inc.collaborator
Study Sites (1)
Asan Medical Center
Seoul, South Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 13, 2026
First Posted
March 23, 2026
Study Start
February 2, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
All individual patient data (IPD) used in this study will be handled in compliance with domestic privacy protection laws and relevant regulations. The privacy of study participants will be strictly safeguarded, and their personal information will not be used for purposes other than the study. When sharing data, only de-identified data that has been approved by the researchers after adequate request will be provided, and privacy protection and security will be prioritized throughout the process.